Medicare Enrolled
Dr. Adnan Peer, MD
Rheumatology · Houston, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Peer from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Peer?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Peer
Dr. Adnan Peer is a rheumatology specialist in Houston, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Peer performed 90,475 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Peer received a total of $44,008 from 51 pharmaceutical and/or device companies across 1364 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Peer is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 17% volume in TX
$44,008 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗90,475
Medicare services
Top 17% in TX for rheumatology
Not available
Unique patients (not deduplicated)
$5
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Certolizumab injection (Cimzia) An injection of certolizumab pegol administered under the direct supervision of a physician. |
86,000 | $4 | $10 |
| Extended-release steroid injection (Zilretta) An injection of triamcinolone acetonide using a preservative-free, extended-release microsphere formulation. The dosage is measured in milligrams. |
1,568 | $13 | $25 |
| Denosumab injection (Prolia/Xgeva) | 1,140 | $19 | $30 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
475 | $91 | $200 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
466 | $57 | $150 |
| Ultrasound-guided large joint aspiration or injection This procedure uses ultrasound imaging to guide the removal of fluid from or the injection of medication into a large joint. |
129 | $103 | $242 |
| Viscosupplementation injection for joint An injection of hyaluronic acid or a derivative into a joint to provide lubrication and cushioning. |
104 | $58 | $100 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
85 | $8 | $10 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
85 | $52 | $250 |
| Injection, methylprednisolone acetate, 40 mg | 62 | $6 | $35 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
57 | $7 | $114 |
| Limited ultrasound of joint or extremity A focused ultrasound exam of a specific joint or other structure in the arm or leg, excluding blood vessels. |
50 | $34 | $60 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
46 | $112 | $300 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
44 | $60 | $100 |
| Influenza vaccine, quadrivalent, 0.5 ml dosage | 33 | $20 | $50 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
32 | $31 | $50 |
| Bone density scan (DEXA) A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures. |
27 | $39 | $100 |
| Methylprednisolone acetate injection, 80 mg An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication. |
22 | $9 | $35 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
17 | $46 | $75 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
17 | $10 | $30 |
| Injection of carpal tunnel | 16 | $68 | $99 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
0.1% high complexity
99.1% medium
0.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$44,008
Total received (2018-2024)
Avg $6,287/year across 7 years
Top 11% in TX for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
51
Companies
1,364
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,363
2023
$10,121
2022
$3,899
2021
$3,068
2020
$2,260
2019
$12,019
2018
$8,278
Payments by company (2024)
Amgen Inc.
$971
ABBVIE INC.
$630
UCB, Inc.
$603
Janssen Biotech, Inc.
$277
AstraZeneca Pharmaceuticals LP
$257
PFIZER INC.
$256
Mallinckrodt Hospital Products Inc.
$198
Novartis Pharmaceuticals Corporation
$193
Aurinia Pharma U.S., Inc.
$174
GlaxoSmithKline, LLC.
$157
Radius Health, Inc.
$138
ANI Pharmaceuticals, Inc.
$73
Biosense Webster, Inc.
$68
E.R. Squibb & Sons, L.L.C.
$62
Kyowa Kirin, Inc.
$62
Sandoz Inc.
$49
Alexion Pharmaceuticals, Inc.
$47
Fidia Pharma USA Inc.
$33
TerSera Therapeutics LLC
$30
GENZYME CORPORATION
$26
Alvogen Inc
$24
Biocon Biologics Inc
$20
SCILEX PHARMACEUTICALS INC.
$16
Top 3 companies account for 50.5% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$5,947
Novartis Pharmaceuticals Corporation
$5,719
GlaxoSmithKline, LLC.
$4,832
Amgen Inc.
$4,804
Horizon Therapeutics plc
$4,056
UCB, Inc.
$2,596
Celgene Corporation
$1,827
ABBVIE INC.
$1,825
Janssen Biotech, Inc.
$1,372
Fresenius Kabi USA, LLC
$1,249
PFIZER INC.
$1,247
Mallinckrodt Hospital Products Inc.
$947
AbbVie Inc.
$837
E.R. Squibb & Sons, L.L.C.
$735
AbbVie, Inc.
$675
GENZYME CORPORATION
$599
Radius Health, Inc.
$464
Aurinia Pharma U.S., Inc.
$464
Lilly USA, LLC
$446
Genentech USA, Inc.
$420
West-Ward Pharmaceuticals
$309
Mallinckrodt Enterprises LLC
$284
Horizon Pharma plc
$237
Johnson & Johnson Health Care Systems Inc.
$231
Sandoz Inc.
$179
McKesson Specialty Care Distribution, LLC
$174
Alexion Pharmaceuticals, Inc.
$162
Actelion Pharmaceuticals US, Inc.
$127
TerSera Therapeutics LLC
$122
Boehringer Ingelheim Pharmaceuticals, Inc.
$110
ANI Pharmaceuticals, Inc.
$105
Cardinal Health 110 LLC
$100
Janssen Scientific Affairs, LLC
$80
Antares Pharma, Inc.
$77
Mallinckrodt LLC
$72
Biosense Webster, Inc.
$68
Hikma Pharmaceuticals USA
$66
Kyowa Kirin, Inc.
$62
SANOFI-AVENTIS U.S. LLC
$54
Mylan Institutional Inc.
$50
Biocon Biologics Inc
$36
Fidia Pharma USA Inc.
$33
IDORSIA PHARMACEUTICALS US INC
$32
Pacira Pharmaceuticals Incorporated
$30
Alvogen Inc
$24
Kiniksa Pharmaceuticals, Ltd.
$24
Phadia US Inc.
$23
MEDAC PHARMA, INC.
$23
Shield Therapeutics Inc
$22
SCILEX PHARMACEUTICALS INC.
$16
DePuy Synthes Sales Inc.
$14
Top 3 companies account for 37.5% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · ACTHAR · AMJEVITA · AVSOLA · Actemra · Arcalyst · BENLYSTA · Bimzelx · CARTO 3 · COSENTYX · CYLTEZO · Cimzia · Crysvita · EVENITY · EVUSHELD · Enbrel · FORTEO · HUMIRA · HYALGAN · HYRIMOZ · Hulio · Humira · IDACIO · ImmunoCAP · Iovera · KEVZARA · KRYSTEXXA · LUPKYNIS · LYRICA · MONOVISC · Mitigare · Neupro · OFEV · ORENCIA · OTREXUP · Otezla · Otrexup · PENNSAID · PURIFIED CORTROPHIN GEL · Prolia · QUVIVIQ · Quzyttir · RAYOS · REMICADE · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · STELARA · STRENSIQ · Strensiq · TALTZ · TAVNEOS · TERIPARATIDE · TREMFYA · Tavneos · Tymlos · UPTRAVI · XELJANZ · ZTLido
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Rheumatologists in nearby ZIP areas
76
County median income
$73,104
Nearest hospital to ZIP centroid (approximate)
HCA HOUSTON HEALTHCARE NORTHWEST
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Peer is a mixed practice specialist, with above-average Medicare volume (top 17% in TX), with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Peer experienced with certolizumab injection (cimzia)?
Based on Medicare claims data, Dr. Peer performed 86,000 certolizumab injection (cimzia) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Peer receive payments from pharmaceutical companies?
Yes. Dr. Peer received a total of $44,008 from 51 companies across 1,364 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Peer's costs compare to other rheumatologists in Houston?
Dr. Peer's average Medicare payment per service is $5. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Peer) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Rheumatologists in Houston
Browse rheumatologists in Houston ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in TX
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in TX
Which TX rheumatologists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology